vs
Side-by-side financial comparison of Greystone Housing Impact Investors LP (GHI) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Greystone Housing Impact Investors LP is the larger business by last-quarter revenue ($15.0M vs $12.6M, roughly 1.2× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -38.9%, a 289.6% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -33.6%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -18.1%).
Greystone Housing Impact Investors LP is a publicly traded real estate investment partnership focused on acquiring, owning, and managing affordable and workforce multifamily housing properties across the United States. It prioritizes investments that generate stable long-term returns while expanding housing access for low and middle income communities.
GHI vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0M | $12.6M |
| Net Profit | $-5.8M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | -33.4% | — |
| Net Margin | -38.9% | 250.7% |
| Revenue YoY | -33.6% | 24080.8% |
| Net Profit YoY | -157.6% | 250.9% |
| EPS (diluted) | $-0.31 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.0M | $12.6M | ||
| Q3 25 | $21.7M | $0 | ||
| Q2 25 | $23.6M | $0 | ||
| Q1 25 | $25.1M | $12.0K | ||
| Q4 24 | $22.6M | $52.0K | ||
| Q3 24 | $24.3M | $65.0K | ||
| Q2 24 | $22.0M | $114.0K | ||
| Q1 24 | $22.4M | $140.0K |
| Q4 25 | $-5.8M | $31.5M | ||
| Q3 25 | $2.0M | $-7.4M | ||
| Q2 25 | $-7.1M | $-1.7M | ||
| Q1 25 | $3.3M | $-13.9M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $-4.6M | $-17.1M | ||
| Q2 24 | $5.2M | $-17.9M | ||
| Q1 24 | $10.6M | $-12.7M |
| Q4 25 | -33.4% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | -30.0% | — | ||
| Q1 25 | 13.2% | -122758.3% | ||
| Q4 24 | 45.0% | — | ||
| Q3 24 | -19.0% | -28604.6% | ||
| Q2 24 | 23.6% | -16720.2% | ||
| Q1 24 | 47.6% | -9987.1% |
| Q4 25 | -38.9% | 250.7% | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | -30.0% | — | ||
| Q1 25 | 13.2% | -115550.0% | ||
| Q4 24 | 44.9% | — | ||
| Q3 24 | -19.0% | -26380.0% | ||
| Q2 24 | 23.6% | -15668.4% | ||
| Q1 24 | 47.6% | -9049.3% |
| Q4 25 | $-0.31 | $0.56 | ||
| Q3 25 | $0.03 | $-0.13 | ||
| Q2 25 | $-0.35 | $-0.03 | ||
| Q1 25 | $0.11 | $-0.25 | ||
| Q4 24 | $0.38 | — | ||
| Q3 24 | $-0.23 | $-0.32 | ||
| Q2 24 | $0.19 | $-0.33 | ||
| Q1 24 | $0.42 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $59.0M |
| Total Assets | $1.5B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $39.5M | $40.3M | ||
| Q3 25 | $36.2M | $48.6M | ||
| Q2 25 | $47.5M | $31.2M | ||
| Q1 25 | $51.4M | $48.9M | ||
| Q4 24 | $14.7M | $52.9M | ||
| Q3 24 | $37.4M | $76.3M | ||
| Q2 24 | $34.0M | $63.5M | ||
| Q1 24 | $56.3M | $82.3M |
| Q4 25 | — | $59.0M | ||
| Q3 25 | — | $26.5M | ||
| Q2 25 | — | $32.8M | ||
| Q1 25 | — | $33.8M | ||
| Q4 24 | — | $46.1M | ||
| Q3 24 | — | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
| Q4 25 | $1.5B | $68.9M | ||
| Q3 25 | $1.5B | $54.2M | ||
| Q2 25 | $1.5B | $62.1M | ||
| Q1 25 | $1.5B | $77.7M | ||
| Q4 24 | $1.6B | $110.5M | ||
| Q3 24 | $1.5B | $135.2M | ||
| Q2 24 | $1.5B | $149.9M | ||
| Q1 24 | $1.5B | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.5M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.5M | $-8.4M | ||
| Q3 25 | $8.4M | $17.4M | ||
| Q2 25 | $10.2M | $-17.7M | ||
| Q1 25 | $10.3M | $-4.0M | ||
| Q4 24 | $18.0M | $-23.4M | ||
| Q3 24 | $4.9M | $12.8M | ||
| Q2 24 | $5.1M | $-18.7M | ||
| Q1 24 | $3.4M | $5.9M |
| Q4 25 | — | -0.26× | ||
| Q3 25 | 4.25× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.11× | — | ||
| Q4 24 | 1.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
